AARDVARK THERAPEUTICS INC (AARD) Stock Analyst Ratings
USA - NASDAQ:AARD - US0029421007 - Common Stock
10.5 USD
+0.7 (+7.14%)
10.5 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to AARD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.06. This target is 205.31% above the current price.
AARD was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about AARD.
In the previous month the buy percentage consensus was at a similar level.
AARD was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-01 | Jones Trading | Initiate | Buy |
| 2025-09-29 | Stifel | Initiate | Buy |
| 2025-09-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-28 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-14 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-05-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-04-01 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-27 | B of A Securities | Maintains | Buy -> Buy |
| 2025-03-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-03-10 | RBC Capital | Initiate | Outperform |
| 2025-03-10 | B of A Securities | Initiate | Buy |
| 2025-03-10 | Morgan Stanley | Initiate | Overweight |
AARDVARK THERAPEUTICS INC / AARD FAQ
What is the price target for AARD stock?
12 analysts have analysed AARD and the average price target is 32.06 USD. This implies a price increase of 205.31% is expected in the next year compared to the current price of 10.5.
What is the consensus rating for AARD stock?
The consensus rating for AARDVARK THERAPEUTICS INC (AARD) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.